UPDATE: BioLineRx (BLRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
(Updated - November 21, 2017 7:06 AM EST)
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Canaccord Starts L1 Group Ltd (L1G:AU) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
